MedTrace Logo

Fosmidomycin and Azithromycin for Acute Uncomplicated Plasmodium Falciparum Malaria (P. Malaria) in Adults

NCT01464125 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 43

Last updated 2011-11-03

No results posted yet for this study

Summary

The aim of this study is to evaluate the role of azithromycin as a possible combination partner for fosmidomycin to protect it from its susceptibility to recrudescent infections when used as monotherapy for acute Plasmodium falciparum malaria while retaining its excellent safety profile.

Conditions

Interventions

DRUG

Fosmidomycin

Fosmidomycin sodium capsules 450 mg x 4 twelve-hourly for three days

DRUG

Azithromycin

Azithromycin capsules 250 mg x 3 twelve-hourly for three days

Sponsors & Collaborators

  • Mahidol University

    collaborator OTHER

  • Thammasat University

    collaborator OTHER

  • Jomaa Pharma GmbH

    lead INDUSTRY

Principal Investigators

  • Srivicha Krudsood, Prof · Mahidol University

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
15 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-11-30
Primary Completion
2009-10-31
Completion
2011-12-31

Countries

  • Thailand

Study Locations

More Related Trials

Entities

Drugs
Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01464125 on ClinicalTrials.gov